Blue Ledge Capital

Blue Ledge Capital is a venture capital investment firm that focuses on early-stage and growth investments in sectors including biotechnology, sustainable food production, and health technologies. The firm operates on a deal-by-deal basis, differentiating itself from traditional venture capital by not charging recurring management fees, instead using low, one-time syndication fees and a standard 20% performance fee. This model allows investors to choose investments on an individual basis. The firm's investment portfolio includes companies like AvantGuard, Qnovia, and Mission Barns.